Furthermore, a recent study revealed the involvement of miR-29 family in CD40 signaling by targeting TRAF4 and proposed a novel regulatory axis in Β-CLL, modulated by the BCR activity [62]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.